PATENT CLAIM ANALYSIS

Application Number: 16135428
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "275000"]

Abstract:
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.

Claim (Index 25):
A compound according to  claim 21 , wherein Ra and Rb are NR5R6, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14212256', '12668745', '13611679', '13140208', '12520387']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8570421781413164
- 35 USC 102 Novelty (BERT): 0.6090273833202263
- Combined Prediction Score: 0.8322406986592075
- Mean Citation Score: 611.9929
- Max Citation Score: 649.7441
- Similarity Product: 444.4639344471812

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test